Cell Death and Disease · 2020 · 42 citations · 47 references
MedicineCancer BiologyOncologyCarcinogenesisChemotherapyMolecular OncologyCancer Cell SignalingChemotherapy ResistanceOncogenic Signaling PathwaysSignal Transduction In CancerTherapeutic ResistanceTumor Suppressor GenesBreast Cancer Resistance MechanismsDrug Resistance ModulationMicrorna-mediated ResistancePregnane X Receptor SignalingResistance To Targeted TherapyTherapeutic Resistance MechanismsTriple-negative Breast Cancer Therapy
The factor that binds to the inducer of short transcripts-1 (FBI-1) is a transcription suppressor and an important proto-oncogene that plays multiple roles in carcinogenesis and therapeutic resistance. In the present work, our results indicated that FBI-1 enhanced the resistance of triple-negative breast cancer (TNBC) cells to chemotherapeutic agents by repressing the expression of micoRNA-30c targeting the pregnane X receptor (PXR). The expression of FBI-1 was positively related to PXR and its downstream drug resistance-related genes in TNBC tissues. FBI-1 enhanced the expression of PXR and enhanced the activation of the PXR pathway. The miR-30c decreased the expression of PXR by targeting the 3'-UTR of PXR, and FBI-1 increased the expression of PXR by repressing miR-30c's expression. Through the miR-30c/PXR axis, FBI-1 accelerated the clearance or elimination of antitumor agents in TNBC cells (the TNBC cell lines or the patients derived cells [PDCs]) and induced the resistance of cells to antitumor agents. Therefore, the results indicated that the miR-30c/PXR axis participates in the FBI-1-mediated drug-resistance of TNBC cells.
47
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Peter Schmid, Hope S. Rugo, Sylvia Adams et al. · The Lancet Oncology · 2019 · 1.2K citations
Medicine, Oncology, Pharmacology +14
Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
Ling Li, Yingchun Liang, Lei Kang et al. · Cancer Cell · 2018 · 435 citations · Full text
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
Marta Bonotto, Lorenzo Gerratana, Elena Poletto et al. · The Oncologist · 2014 · 289 citations · Full text
Medicine, Biostatistics, Oncology +17